Locations:
Search IconSearch

Pulmonary

22-NEU-2768409_neuropsych-treatment_650x450

Neuropsychiatric Management of the ICU Survivor

Guidance for treatment, including the role of post-ICU recovery clinics

22-PUL-2725608 CQD Critical Care Among Disadvantaged Minority Groups 650×450
March 23, 2022/Pulmonary/Research

New Findings Illustrate How Standardized Care Reduces Disparities in the ICU

A recent study shows how equitable care can be achieved

21-HVI-2595510_aortic-aneurysm_650x450

Case Study: When Lung Transplant Evaluation Reveals a Large Abdominal Aortic Aneurysm

How to time the interventions, and how to manage anesthesia risks?

Lung transplant

Consensus Document Offers New Guidance for Lung Transplants

Criteria reflect a rethinking of some contraindications

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Researcher in lab
March 7, 2022/Pulmonary/Research

Cleveland Clinic’s Innovative Program Supports Next Generation of Respiratory Physician and Scientist Investigators

The SMARRT program, developed through a T32 grant from the NIH, promotes an entire curriculum of scholarship, training and mentoring for participants

21-NEU-2437863 hypoglossal-nerve-stimulation-OSA_650x450
March 2, 2022/Neurosciences/Podcast

Neurostimulation for Treatment of Obstructive Sleep Apnea (Podcast)

An in-depth look at this alternative for patients who cannot tolerate PAP therapy

ARDS
February 10, 2022/Pulmonary/Research

Context Matters: How the Paradigm for Studying Pulmonary Fibrosis is Changing

Research from three pulmonologists is shining light on mechanotransduction and ECM signal processing in ways that could lead to new therapeutic options

COVID-19 ICU bed
February 8, 2022/COVID-19

How Cleveland Clinic Used Regional ICUs to Alleviate COVID-19 Surges

Due in part to a unique infrastructure model along with consistent communication at all levels, Cleveland Clinic was able to remain agile in its response to the COVID-19 pandemic

21-PUL-2348986_neurosarcoidosis-pathology_650x450
February 3, 2022/Neurosciences

In Neurosarcoidosis, Tools for Disease Monitoring May Finally Be at Hand

Study clears way for efforts to validate the NIH Toolbox Motor Battery

Eosinophil
January 28, 2022/Pulmonary/Research

Eosinophilia as a Potential Biomarker to Guide Inhaled Corticosteroid Therapy in COVID-19 Treatments

New findings from a large retrospective study illustrate how understanding a patient’s pre-existing immune profile might impact COVID-19 outcomes

BackPage 9 of 33Next

Advertisement

Ad